Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf, Anamaria Brozović, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100645-100645
Closed Access | Times Cited: 438
Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy
Elena De Mattia, Erika Cecchin, Giuseppe Toffoli
Drug Resistance Updates (2015) Vol. 20, pp. 39-70
Closed Access | Times Cited: 79
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
John P. Veluchamy, Jan Spanholtz, Marleen Tordoir, et al.
PLoS ONE (2016) Vol. 11, Iss. 6, pp. e0157830-e0157830
Open Access | Times Cited: 75
Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
Cristiana Lo Nigro, Vincenzo Ricci, Daniela Vivenza, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 30, pp. 6944-6944
Open Access | Times Cited: 62
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
Daphne Bertholee, Jan Gerard Maring, André B. P. Kuilenburg
Clinical Pharmacokinetics (2016) Vol. 56, Iss. 4, pp. 317-337
Open Access | Times Cited: 61
The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer
Joanne B. Weidhaas, Jonathan Harris, Dörthe Schaue, et al.
JAMA Oncology (2016) Vol. 3, Iss. 4, pp. 483-483
Open Access | Times Cited: 58
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
Xin Zhao, Han Li, Shaocheng Lyu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 10, pp. 2590-2605
Open Access | Times Cited: 35
FcγR requirements leading to successful immunotherapy
Lekh N. Dahal, Ali Roghanian, Stephen A. Beers, et al.
Immunological Reviews (2015) Vol. 268, Iss. 1, pp. 104-122
Closed Access | Times Cited: 43
Enhanced expression of FCER1G predicts positive prognosis in multiple myeloma
Lin Fu, Zhiheng Cheng, Fen Dong, et al.
Journal of Cancer (2019) Vol. 11, Iss. 5, pp. 1182-1194
Open Access | Times Cited: 38
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer
Geoffrey Liu, Dongsheng Tu, Marcia Lewis, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 10, pp. 2435-2444
Open Access | Times Cited: 36
Drug resistance: from bacteria to cancer
Harsh Patel, Zhuo‐Xun Wu, Yanglu Chen, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 26
Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response inKRASwild-type metastatic colorectal cancer patients
Cristiana Lo Nigro
World Journal of Gastrointestinal Oncology (2016) Vol. 8, Iss. 2, pp. 222-222
Open Access | Times Cited: 27
Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis
Mi Li, Xin Jin, Hao Li, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Fc‐gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer
Daniel Shepshelovich, Amanda Townsend, Osvaldo Espin‐Garcia, et al.
Cancer Medicine (2018) Vol. 7, Iss. 11, pp. 5478-5487
Open Access | Times Cited: 22
Creation of culture media for efficient duckweeds micropropagation (Wolffia arrhiza and Lemna minor) using artificial mathematical optimization models
Pavel Khvatkov, Mariya Chernobrovkina, Anna Okuneva, et al.
Plant Cell Tissue and Organ Culture (PCTOC) (2018) Vol. 136, Iss. 1, pp. 85-100
Closed Access | Times Cited: 17
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck
Rosalyn A. Juergens, Scott V. Bratman, Ming‐Sound Tsao, et al.
Cancer Treatment Reviews (2017) Vol. 54, pp. 43-57
Closed Access | Times Cited: 15
Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis
H. Li, Zhe Jin, X. Li, et al.
Clinical & Translational Oncology (2017) Vol. 19, Iss. 8, pp. 1018-1027
Closed Access | Times Cited: 15
Genetic Markers of the Host to Predict the Efficacy of Colorectal Cancer Targeted Therapy
Elena De Mattia, Alessia Bignucolo, Giuseppe Toffoli, et al.
Current Medicinal Chemistry (2019) Vol. 27, Iss. 25, pp. 4249-4273
Closed Access | Times Cited: 13
Using Mathematical Optimization Models to Improve the Efficiency of Duckweeds (Wolffia arrhiza and Lemna minor) Micropropagation
Pavel Khvatkov, Sergey Dolgov
Methods in molecular biology (2024), pp. 85-98
Closed Access | Times Cited: 1
FCGR2A, FCGR3Apolymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer
Hou‐Qun Ying, Feng Wang, Xiaolin Chen, et al.
Oncotarget (2015) Vol. 6, Iss. 29, pp. 28071-28083
Open Access | Times Cited: 11
Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic
Jin Kim, Ji Young Lee, Han Gil Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9489-9489
Open Access | Times Cited: 10
Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies
Michelle M. Stein, Cara L. Hrusch, Anne I. Sperling, et al.
Genes and Immunity (2018) Vol. 20, Iss. 6, pp. 462-472
Open Access | Times Cited: 11
Effects of Immuno-Related Gene Polymorphisms on a Bispecific Antibody Targeting Colorectal Cancer Cell
Congmin Zhang, Linyu Yu, Jinfeng Lv, et al.
Personalized Medicine (2018) Vol. 15, Iss. 3, pp. 167-179
Closed Access | Times Cited: 9
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation
Hannah Bauer-Smith, Abigail S. L. Sudol, Stephen A. Beers, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 11, pp. 130448-130448
Open Access | Times Cited: 3
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin‑based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials
Hiromichi Maeda, Shoichi Hazama, Shigeyoshi Iwamoto, et al.
Oncology Letters (2019)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top